Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

September 30, 2019 at 8:30 AM EDT

 BRISBANE, Calif.--(BUSINESS WIRE)--Sep. 30, 2019-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

 Cell & Gene Meeting on the Mesa 2019
Corporate presentation
Wednesday, Oct 2nd at 3:15 p.m. Pacific Time 
Location: Carlsbad, CA 

Panel: What does the future hold for gene editing?
Friday, Oct 4th at 9:45 a.m. Pacific Time 
Location: Carlsbad, CA 

 Cantor Global Healthcare Conference 2019
Friday, Oct 4th at 11:15 a.m. Eastern Time 
Location: New York, NY 

 Chardan 3rd Annual Genetic Medicines Conference 
Monday, Oct 7th at 8:30 a.m. Eastern Time 
Location: New York, NY 

 Jefferies Gene Therapy/Editing Summit
Tuesday, Oct 8th at 11:15 a.m. Eastern Time 
Location: New York, NY 

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.

 About Sangamo Therapeutics  

 Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Source: Sangamo Therapeutics, Inc.

Investor Relations – Global
McDavid Stilwell
510-970-6000, x219
mstilwell@sangamo.com 

Media Inquiries – Global
Aron Feingold
510-970-6000, x421
afeingold@sangamo.com